Company intelligence / Profile preview
Matinas BioPharma
Bedminster, New Jersey, United Statesmatinasbiopharma.com ↗
- Ownership
- Public · MTNB
- Employees
- ~15
- Development stage
- Phase 3
01
Overview
MAT2203 demonstrated positive results in the completed Phase II EnACT study for cryptococcal meningitis in HIV patients—meeting its primary endpoint with robust survival data. However, following the termination of a key partnership negotiation in late October/early November 2024, all product development activities have been halted to conserve cash. The company implemented an immediate ~80% workforce reduction.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculesOligonucleotides (including mRNA, DNA plasmids, antisense oligonucleotides)Proteins and peptidesVaccines
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
BioNTech SE – evaluation of mRNA formats with LNC platformGenentech Inc. – oral formulations collaborationNational Institute of Allergy and Infectious Diseases – remdesivir oral formulation projectNational Resilience – technology/data collaboration
Beyond the preview
Go deeper on Matinas BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Matinas BioPharma.